{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:51:13Z","timestamp":1760921473437,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.cyto.2015.04.020","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T01:19:03Z","timestamp":1435022343000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Decreased serum level of IL-7 in patients with active Graves\u2019 disease"],"prefix":"10.1016","volume":"75","author":[{"given":"Ewelina","family":"Motylewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martyna","family":"Nie\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Siejka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"\u0141awnicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"\u015awi\u0119tos\u0142awski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henryk","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cyto.2015.04.020_b0005","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s10067-013-2360-x","article-title":"Perspectives of the relationship between IL-7 and autoimmune diseases","volume":"32","author":"Wang","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"4\u20135","key":"10.1016\/j.cyto.2015.04.020_b0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cytogfr.2005.05.004","article-title":"Cell biology of IL-7, a key lymphotrophin","volume":"16","author":"Jiang","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6173","key":"10.1016\/j.cyto.2015.04.020_b0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/333571a0","article-title":"Stimulation of B-cell progenitors by cloned murine interleukin-7","volume":"333","author":"Namen","year":"1988","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cyto.2015.04.020_b0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1471-4906(01)02028-2","article-title":"Interleukin-7: master regulator of peripheral T-cell homeostasis?","volume":"22","author":"Fry","year":"2001","journal-title":"Trends Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2015.04.020_b0025","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood.V99.11.3892","article-title":"Interleukin-7: from bench to clinic","volume":"99","author":"Fry","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cyto.2015.04.020_b0030","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.4049\/jimmunol.0900190","article-title":"Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients","volume":"182","author":"Rose","year":"2009","journal-title":"J Immunol."},{"key":"10.1016\/j.cyto.2015.04.020_b0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2013.06.007","article-title":"Interleukin-7: Fuel for the autoimmune attack","volume":"45","author":"Dooms","year":"2013","journal-title":"J Autoimmun"},{"issue":"17","key":"10.1016\/j.cyto.2015.04.020_b0040","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves\u2019 disease","volume":"343","author":"Weetman","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cyto.2015.04.020_b0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/er.2013-1055","article-title":"Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity","volume":"35","author":"McLachlan","year":"2014","journal-title":"Endocr Rev"},{"issue":"1\u20133","key":"10.1016\/j.cyto.2015.04.020_b0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12026-012-8312-8","article-title":"Delineating the autoimmune mechanisms in Graves\u2019 disease","volume":"54","author":"Morshed","year":"2012","journal-title":"Immunol Res"},{"issue":"11","key":"10.1016\/j.cyto.2015.04.020_b0055","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1210\/jc.2014-3011","article-title":"Graves\u2019 hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease","volume":"99","author":"Rapoport","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cyto.2015.04.020_b0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy","volume":"18","author":"Bartalena","year":"2008","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.cyto.2015.04.020_b0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/08916934.2012.751981","article-title":"Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases","volume":"46","author":"Bossowski","year":"2013","journal-title":"Autoimmunity"},{"issue":"7","key":"10.1016\/j.cyto.2015.04.020_b0070","doi-asserted-by":"crossref","first-page":"e68446","DOI":"10.1371\/journal.pone.0068446","article-title":"A high frequency of circulating th22 and th17 cells in patients with new onset Graves\u2019 disease","volume":"8","author":"Peng","year":"2013","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.cyto.2015.04.020_b0075","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.4049\/jimmunol.1201286","article-title":"IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells","volume":"189","author":"Heninger","year":"2012","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2015.04.020_b0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm.2077","article-title":"Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease","volume":"16","author":"Liu","year":"2010","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.cyto.2015.04.020_b0085","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2174\/138161212800165979","article-title":"Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction","volume":"18","author":"Bikker","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.cyto.2015.04.020_b0090","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.smim.2012.02.005","article-title":"IL-7 in human health and disease","volume":"24","author":"Lundstr\u00f6m","year":"2012","journal-title":"Semin Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2015.04.020_b0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/thy.2006.16.295","volume":"16","author":"Carella","year":"2006","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.cyto.2015.04.020_b0100","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves\u2019 orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.cyto.2015.04.020_b0105","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical review: clinical utility of TSH receptor antibodies","volume":"98","author":"Barbesino","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"31","key":"10.1016\/j.cyto.2015.04.020_b0110","doi-asserted-by":"crossref","first-page":"12668","DOI":"10.1073\/pnas.1203692109","article-title":"IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector\/memory T cells","volume":"109","author":"Penaranda","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"31","key":"10.1016\/j.cyto.2015.04.020_b0115","doi-asserted-by":"crossref","first-page":"12674","DOI":"10.1073\/pnas.1203795109","article-title":"Anti-IL-7 receptor-\u03b1 reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.cyto.2015.04.020_b0120","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/art.27318","article-title":"Increased expression of interleukin-7 in labial salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome correlates with increased inflammation","volume":"62","author":"Bikker","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.cyto.2015.04.020_b0125","doi-asserted-by":"crossref","first-page":"e27528","DOI":"10.1371\/journal.pone.0027528","article-title":"Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7R\u03b1 blockade","volume":"6","author":"Gonzalez-Quintial","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.cyto.2015.04.020_b0130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/annrheumdis-2012-202377","article-title":"Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levels","volume":"72","author":"Go\u00ebb","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.cyto.2015.04.020_b0135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1572-0241.2005.40819.x","article-title":"Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn\u2019s disease and ulcerative colitis patients in remission versus active disease","volume":"100","author":"Kader","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cyto.2015.04.020_b0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/gene.2012.34","article-title":"Decreased systemic IL-7 and soluble IL-7R\u03b1 in multiple sclerosis patients","volume":"13","author":"Kreft","year":"2012","journal-title":"Genes Immun"},{"issue":"3 Suppl 54","key":"10.1016\/j.cyto.2015.04.020_b0145","first-page":"68","article-title":"Decreased serum IL-7 levels in patients with systemic sclerosis","volume":"27","author":"Makino","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.cyto.2015.04.020_b0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12020-012-9840-7","article-title":"Interleukin-7 expression in tears and orbital tissues of patients with Graves\u2019 ophthalmopathy","volume":"44","author":"Cai","year":"2013","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.cyto.2015.04.020_b0155","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/labinvest.3780157","article-title":"Expression of interleukin-7 and its receptor in thyroid lymphoma","volume":"80","author":"Takakuwa","year":"2000","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.cyto.2015.04.020_b0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.159.1.117","article-title":"TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors","volume":"159","author":"Tang","year":"1997","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.cyto.2015.04.020_b0165","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jnci\/87.8.593","article-title":"Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7","volume":"87","author":"Dubinett","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2015.04.020_b0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.imlet.2013.12.019","article-title":"IL-7 inhibits tumor growth by promoting T cell-mediated antitumor immunity in Meth A model","volume":"158","author":"Tang","year":"2014","journal-title":"Immunol Lett"},{"issue":"3","key":"10.1016\/j.cyto.2015.04.020_b0175","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.2007.03575.x","article-title":"The +869T\/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease","volume":"151","author":"Yamada","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"24","key":"10.1016\/j.cyto.2015.04.020_b0180","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/01.CIR.101.24.2783","article-title":"Association of a T29\u2192C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese","volume":"101","author":"Yokota","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cyto.2015.04.020_b0185","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/147323001003800418","article-title":"Influence of thyroid hormones and transforming growth factor-\u03b21 on cystatin C concentrations","volume":"38","author":"Kotajima","year":"2010","journal-title":"J Int Med Res"},{"issue":"2","key":"10.1016\/j.cyto.2015.04.020_b0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2265.2008.03192.x","article-title":"Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves\u2019 hyperthyroidism: a prospective study","volume":"69","author":"Vos","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.cyto.2015.04.020_b0195","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng2103","article-title":"Multiple sclerosis genetics group. interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis","volume":"39","author":"Gregory","year":"2007","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.cyto.2015.04.020_b0200","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ng2068","article-title":"Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes","volume":"39","author":"Todd","year":"2007","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.cyto.2015.04.020_b0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.cyto.2015.04.020_b0210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","article-title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","volume":"43","author":"Anderson","year":"2011","journal-title":"Nat Genet"},{"issue":"19","key":"10.1016\/j.cyto.2015.04.020_b0215","doi-asserted-by":"crossref","first-page":"E1761","DOI":"10.1073\/pnas.1222303110","article-title":"Soluble IL7R\u03b1 potentiates IL-7 bioactivity and promotes autoimmunity","volume":"110","author":"Lundstr\u00f6m","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.cyto.2015.04.020_b0220","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/annrheumdis-2012-202364","article-title":"Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus","volume":"72","author":"Badot","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.cyto.2015.04.020_b0225","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1582-4934.2010.01228.x","article-title":"Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines","volume":"15","author":"Badot","year":"2011","journal-title":"J Cell Mol Med"},{"issue":"7","key":"10.1016\/j.cyto.2015.04.020_b0230","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.2337\/db12-1726","article-title":"Concentration and activity of the soluble form of the interleukin-7 receptor \u03b1 in type 1 diabetes identifies an interplay between hyperglycemia and immune function","volume":"62","author":"Monti","year":"2013","journal-title":"Diabetes"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615002422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615002422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:49:46Z","timestamp":1760906986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615002422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1043466615002422"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.04.020","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased serum level of IL-7 in patients with active Graves\u2019 disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}